217 related articles for article (PubMed ID: 15296849)
21. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
Chen HQ; Jin ZY; Li GH
Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss.
Song DY; Yu HN; Park CR; Lee JS; Lee JY; Park BG; Woo RS; Han JT; Cho BP; Baik TK
BMC Neurosci; 2013 Oct; 14():112. PubMed ID: 24093518
[TBL] [Abstract][Full Text] [Related]
23. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes.
Revuelta M; Venero JL; Machado A; Cano J
Glia; 1997 Oct; 21(2):204-16. PubMed ID: 9336235
[TBL] [Abstract][Full Text] [Related]
24. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
[TBL] [Abstract][Full Text] [Related]
25. Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.
Won SY; Choi SH; Jin BK
J Neuroimmunol; 2009 Sep; 214(1-2):83-92. PubMed ID: 19660816
[TBL] [Abstract][Full Text] [Related]
26. Microglial phagocytosis of dopamine neurons at early phases of apoptosis.
Cho BP; Sugama S; Shin DH; DeGiorgio LA; Kim SS; Kim YS; Lim SY; Park KC; Volpe BT; Cho S; Joh TH
Cell Mol Neurobiol; 2003 Oct; 23(4-5):551-60. PubMed ID: 14514015
[TBL] [Abstract][Full Text] [Related]
27. Norepinephrine protects cortical neurons against microglial-induced cell death.
Madrigal JL; Feinstein DL; Dello Russo C
J Neurosci Res; 2005 Aug; 81(3):390-6. PubMed ID: 15948176
[TBL] [Abstract][Full Text] [Related]
28. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
[TBL] [Abstract][Full Text] [Related]
29. Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP.
Liu L; Hsu SS; Kalia SK; Lozano AM
Brain Res; 2003 Dec; 994(2):243-52. PubMed ID: 14642650
[TBL] [Abstract][Full Text] [Related]
30. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
[TBL] [Abstract][Full Text] [Related]
31. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
Ferrari CC; Pott Godoy MC; Tarelli R; Chertoff M; Depino AM; Pitossi FJ
Neurobiol Dis; 2006 Oct; 24(1):183-93. PubMed ID: 16901708
[TBL] [Abstract][Full Text] [Related]
32. [Protective effect of tripchlorolide on dopaminergic neurons in partially lesioned rat model of Parkinson's disease].
Cheng XX; Li FQ; Huang M; Wang XM; Han JS
Yao Xue Xue Bao; 2002 May; 37(5):339-42. PubMed ID: 12579836
[TBL] [Abstract][Full Text] [Related]
33. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons.
Wessig J; Brecht S; Claussen M; Roemer L; Goetz M; Bigini P; Schutze S; Herdegen T
Eur J Neurosci; 2005 Jul; 22(1):267-72. PubMed ID: 16029216
[TBL] [Abstract][Full Text] [Related]
35. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
[TBL] [Abstract][Full Text] [Related]
37. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
38. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.
Tseng JL; Baetge EE; Zurn AD; Aebischer P
J Neurosci; 1997 Jan; 17(1):325-33. PubMed ID: 8987758
[TBL] [Abstract][Full Text] [Related]
39. Differential spatial and temporal gene expression in response to axotomy and deafferentation following transection of the medial forebrain bundle.
Weiser M; Baker H; Wessel TC; Joh TH
J Neurosci; 1993 Aug; 13(8):3472-84. PubMed ID: 8101870
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
Arimoto T; Choi DY; Lu X; Liu M; Nguyen XV; Zheng N; Stewart CA; Kim HC; Bing G
Neurobiol Aging; 2007 Jun; 28(6):894-906. PubMed ID: 21887889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
